BridgeBio Alternatives & Competitors
12 companies similar to BridgeBio — We move at the speed of patient need.
Companies similar to BridgeBio
Ultragenyx
Going Beyond Every Day
Walden Biosciences
Transforming the Treatment of Kidney Disease
Ractigen Therapeutics
Turn on genes and turn off diseases
Rival Readout
Competing with BridgeBio? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
VectivBio
Biotech company develops treatments for severe rare diseases, aims to become global leader...
Berlin Institute of Health in der Charité
Aus Forschung wird Gesundheit
Be Biopharma
Engineered B cells as medicines
BlossomHill Therapeutics, Inc.
Addressing urgent unmet medical needs through deeper science, true originality, and rich e...
Calluna Pharma
Developing first-in-class therapies designed to defeat chronic inflammation and fibrosis a...
Alumis
Transforming the lives of patients living with immune-mediated diseases using a precision...
ACELYRIN, INC.
We are a late-stage clinical biopharma company focused on providing life-changing new trea...
About BridgeBio
BridgeBio, founded in 2014, is a U.S.-based biotech company focused on delivering transformative medicines for genetic conditions, seeking to align genetic and entrepreneurial advances. Their slogan, "We move at the speed of patient need," encapsulates their mission to address urgent patient requirements through innova...
drug research and development, clinical trials and testing, regulatory submissions, patient support and advocacy, scientific publications and presentations
patients with rare genetic conditions, healthcare providers, medical researchers, pharmacists, biotechnology investors
Genetic Medicine, Genetic Disease Therapies, R&D Support, Transformative Medicines, Entrepreneurial Approach, Patient-centric Innovation, Scientific Advancement, Therapeutic Development, Rapid Drug Development, Unmet Medical Needs, Patient Impact, Genetics Science Integration, Problem-solving In Biotech, Leadership In Biotech
B2B, B2C, D2C
Product Sales, Licensing, Service Fee
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BridgeBio: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BridgeBio on 11 Mar 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.